Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

321 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Trends in respiratory virus circulation following COVID-19-targeted nonpharmaceutical interventions in Germany, January - September 2020: Analysis of national surveillance data.
Oh DY, Buda S, Biere B, Reiche J, Schlosser F, Duwe S, Wedde M, von Kleist M, Mielke M, Wolff T, Dürrwald R. Oh DY, et al. Among authors: buda s. Lancet Reg Health Eur. 2021 Jul;6:100112. doi: 10.1016/j.lanepe.2021.100112. Epub 2021 Jun 7. Lancet Reg Health Eur. 2021. PMID: 34124707 Free PMC article.
Influenza A(H1N1)v in Germany: the first 10,000 cases.
Gilsdorf A, Poggensee G; Working Group Pandemic Influenza A(H1N1)v. Gilsdorf A, et al. Euro Surveill. 2009 Aug 27;14(34):19318. doi: 10.2807/ese.14.34.19318-en. Euro Surveill. 2009. PMID: 19712649 Free article.
Communicable diseases prioritized for surveillance and epidemiological research: results of a standardized prioritization procedure in Germany, 2011.
Balabanova Y, Gilsdorf A, Buda S, Burger R, Eckmanns T, Gärtner B, Gross U, Haas W, Hamouda O, Hübner J, Jänisch T, Kist M, Kramer MH, Ledig T, Mielke M, Pulz M, Stark K, Suttorp N, Ulbrich U, Wichmann O, Krause G. Balabanova Y, et al. Among authors: buda s. PLoS One. 2011;6(10):e25691. doi: 10.1371/journal.pone.0025691. Epub 2011 Oct 4. PLoS One. 2011. PMID: 21991334 Free PMC article.
The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2).
Valenciano M, Kissling E, Reuss A, Jiménez-Jorge S, Horváth JK, Donnell JM, Pitigoi D, Machado A, Pozo F; I-MOVE Multicentre Case Control Study Team. Valenciano M, et al. Vaccine. 2015 Jun 4;33(24):2813-22. doi: 10.1016/j.vaccine.2015.04.012. Epub 2015 Apr 28. Vaccine. 2015. PMID: 25936723 Free article.
Erratum to "Predominance of influenza A(H3N2) virus genetic subclade 3C.2a1 during an early 2016/17 influenza season in Europe - Contribution of surveillance data from World Health Organization (WHO) European region to the WHO vaccine composition consultation for northern hemisphere 2017/18" [Vaccine 35 (2017) 4828-4835].
Melidou A, Broberg E; European region influenza surveillance network. Melidou A, et al. Vaccine. 2018 May 3;36(19):2740-2741. doi: 10.1016/j.vaccine.2017.12.039. Epub 2017 Dec 20. Vaccine. 2018. PMID: 29274700 Free article. No abstract available.
321 results